TY  - CHAP
M1  - Book, Section
TI  - Cancer Chemotherapy
A1  - Jobst, Erin E.
A1  - Panus, Peter C.
A1  - Kruidering-Hall, Marieke
PY  - 2020
T2  - Pharmacology for the Physical Therapist, 2e
AB  - CASE  STUDYP.Y.  is  a  42-year-old  man  diagnosed  with  chronic  myelogenous  leukemia  (CML)  in  the  chronic  phase.  He  has  been  taking  the  tyrosine  kinase  inhibitor  imatinib  daily  for  the  past  3  months.  At  a  scheduled  evaluation  with  his  oncologist,  it  was  discovered  that  the  leukemia  was  not  responding  well.  As  a  first  option,  the  oncologist  decided  to  increase  the  imatinib  dose.  Within  a  couple  weeks,  P.Y.  began  experiencing  significant  muscle  pain  and  difficulty  breathing.  On  a  Friday  night,  his  breathing  became  so  labored  and  difficult  that  P.Y.  went  to  the  emergency  department.  He  was  admitted  to  the  hospital  for  evaluation  of  these  new  symptoms.  As  part  of  the  admission,  a  physical  therapy  consult  was  automatically  ordered.  On  Saturday,  the  physical  therapist  reviewed  the  patient’s  electronic  medical  record  and  discussed  the  case  with  the  on-call  oncology  fellow  before  seeing  the  patient.  After  discussion  with  the  physician,  they  decided  that  the  physical  therapy  evaluation  should  be  deferred  for  a  few  days.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/23
UR  - accessphysiotherapy.mhmedical.com/content.aspx?aid=1192818974
ER  -